somatostatin analogue
Octreotide companies
Answer
Public registers name 17 licence holders, 18 bulk ingredient labelers, 13 US labelers, 155 trial sponsors and 5 recalling firms for Octreotide.
Each row is what a register states. A company named here is not endorsed or accused by this site.
MARKETING AUTHORISATION HOLDER
17 companies
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Amryt Pharmaceuticals DAC | Mycapssa (EMEA/H/C/005826), Withdrawn Regulator EMA |
|---|---|
| Camurus AB | Oczyesa (EMEA/H/C/006322), Authorised Regulator EMA OCZYESA 20 MG PROLONGED-RELEASE SOLUTION FOR INJECTION IN PRE-FILLED PEN, PL 42800/0011, Authorised Regulator MHRA |
| CHEMI SPA MILAN ITALY | OCTREOTIDE 100 MICROGRAMS/ML SOLUTION FOR INJECTION IN PREFILLED SYRINGE, PL 04465/0006, Authorised Regulator MHRA OCTREOTIDE 50 MICROGRAMS/ML SOLUTION FOR INJECTION IN PREFILLED SYRINGE, PL 04465/0005, Authorised Regulator MHRA OCTREOTIDE 500 MICROGRAMS/ML SOLUTION FOR INJECTION IN PREFILLED SYRINGE, PL 04465/0007, Authorised Regulator MHRA |
| GENERIC MEDICAL PARTNERS INC | OCTREOTIDE ACETATE INJECTION (DIN 02509741), Approved Regulator Health Canada OCTREOTIDE ACETATE INJECTION (DIN 02509768), Approved Regulator Health Canada OCTREOTIDE ACETATE INJECTION (DIN 02509776), Approved Regulator Health Canada |
| HOSPIRA UK LIMITED | OCTREOTIDE 100 MICROGRAMS/1 ML SOLUTION FOR INJECTION, PL 04515/0218, Authorised Regulator MHRA OCTREOTIDE 50 MICROGRAMS/1 ML SOLUTION FOR INJECTION, PL 04515/0217, Authorised Regulator MHRA OCTREOTIDE 500 MICROGRAMS/1 ML SOLUTION FOR INJECTION, PL 04515/0220, Authorised Regulator MHRA |
| MONT-PHARMA INC | OCTREOTIDE INJECTION (DIN 02535890), Approved Regulator Health Canada OCTREOTIDE INJECTION (DIN 02535904), Approved Regulator Health Canada OCTREOTIDE INJECTION (DIN 02535912), Approved Regulator Health Canada and 1 more entries |
| NOVARTIS IRELAND LIMITED | SANDOSTATIN AMPOULES 100 MCG/ML SOLUTION FOR INJECTION OR CONCENTRATE FOR SOLUTION FOR INFUSION, PL 23860/0031, Authorised Regulator MHRA SANDOSTATIN AMPOULES 50 MCG/ML SOLUTION FOR INJECTION OR CONCENTRATE FOR SOLUTION FOR INFUSION, PL 23860/0030, Authorised Regulator MHRA SANDOSTATIN AMPOULES 500 MCG/ML SOLUTION FOR INJECTION OR CONCENTRATE FOR SOLUTION FOR INFUSION, PL 23860/0032, Authorised Regulator MHRA and 3 more entries |
| NOVARTIS PHARMACEUTICALS CANADA INC | SANDOSTATIN (DIN 00839191), Marketed Regulator Health Canada SANDOSTATIN (DIN 00839205), Cancelled Post Market Regulator Health Canada SANDOSTATIN (DIN 00839213), Cancelled Post Market Regulator Health Canada and 4 more entries |
| OMEGA LABORATORIES LIMITED | OCTREOTIDE ACETATE OMEGA (DIN 02248639), Marketed Regulator Health Canada OCTREOTIDE ACETATE OMEGA (DIN 02248640), Marketed Regulator Health Canada OCTREOTIDE ACETATE OMEGA (DIN 02248641), Marketed Regulator Health Canada and 1 more entries |
| PENDOPHARM DIVISION OF PHARMASCIENCE INC | OCPHYL (DIN 02413191), Cancelled Post Market Regulator Health Canada OCPHYL (DIN 02413205), Cancelled Post Market Regulator Health Canada OCPHYL (DIN 02413213), Cancelled Post Market Regulator Health Canada |
| ROTOP PHARMAKA GMBH | TEKTROTYD 16 MICROGRAM KIT FOR RADIOPHARMACEUTICAL PREPARATION, PL 45925/0001, Authorised Regulator MHRA |
| SANDOZ CANADA INCORPORATED | OCTREOTIDE ACETATE INJECTION - 100MCG/ML (DIN 02263173), Cancelled Pre Market Regulator Health Canada OCTREOTIDE ACETATE INJECTION - 200MCG/ML (DIN 02263181), Cancelled Pre Market Regulator Health Canada OCTREOTIDE ACETATE INJECTION - 500MCG/ML (DIN 02263203), Cancelled Pre Market Regulator Health Canada and 1 more entries |
| SEACROSS PHARMACEUTICALS LIMITED | OCTREOTIDE 100 MICROGRAM/ML SOLUTION FOR INJECTION/INFUSION, PL 41013/0024, Authorised Regulator MHRA |
| STERIMAX INC | OCTREOTIDE DEPOT (DIN 02567776), Marketed Regulator Health Canada OCTREOTIDE DEPOT (DIN 02567784), Marketed Regulator Health Canada OCTREOTIDE DEPOT (DIN 02567792), Marketed Regulator Health Canada and 3 more entries |
| SUN PHARMACEUTICAL INDUSTRIES EUROPE BV | OCTREOTIDE 100 MICROGRAMS/ML SOLUTION FOR INJECTION, PL 31750/0084, Authorised Regulator MHRA OCTREOTIDE 200 MICROGRAMS/ML SOLUTION FOR INJECTION, PL 31750/0086, Authorised Regulator MHRA OCTREOTIDE 50 MICROGRAMS/ML SOLUTION FOR INJECTION, PL 31750/0083, Authorised Regulator MHRA and 1 more entries |
| TEVA CANADA LIMITED | OCTREOTIDE FOR INJECTABLE SUSPENSION (DIN 02503751), Cancelled Post Market Regulator Health Canada OCTREOTIDE FOR INJECTABLE SUSPENSION (DIN 02503778), Cancelled Post Market Regulator Health Canada OCTREOTIDE FOR INJECTABLE SUSPENSION (DIN 02503786), Cancelled Post Market Regulator Health Canada and 4 more entries |
| TEVA UK LIMITED | OLATUTON 10 MG POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION, PL 00289/2219, Authorised Regulator MHRA OLATUTON 20 MG POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION, PL 00289/2220, Authorised Regulator MHRA OLATUTON 30 MG POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION, PL 00289/2221, Authorised Regulator MHRA |
BULK INGREDIENT LABELER
18 companies
Lists the bulk active ingredient with FDA (NDC directory).
| Ambiopharm, Inc. | Octreotide, BULK INGREDIENT Regulator openFDA |
|---|---|
| Assia Chemical Industries Ltd - Teva Tech Site | Octreotide Acetate, BULK INGREDIENT Regulator openFDA |
| Aurobindo Pharma Limited | Octreotide Acetate, BULK INGREDIENT Regulator openFDA |
| Bachem AG | Octreotide Acetate, BULK INGREDIENT Regulator openFDA Octreotide Hydrochloride, BULK INGREDIENT Regulator openFDA |
| Bachem Americas, Inc. | Octreotide Acetate, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING Regulator openFDA Octreotide, BULK INGREDIENT Regulator openFDA |
| BCN PEPTIDES SA | Octreotide, BULK INGREDIENT Regulator openFDA |
| Chemical & Biopharmaceutical Laboratories of Patras Single Member S.A. | Octreotide acetate, BULK INGREDIENT Regulator openFDA |
| Chengdu Shengnuo Biopharm Co. Ltd. | Octreotide Acetate, BULK INGREDIENT Regulator openFDA |
| FRESENIUS KABI IPSUM SRL | OCTREOTIDE ACETATE, BULK INGREDIENT Regulator openFDA |
| Hainan Shuangcheng Pharmaceuticals Co., Ltd. | octreotide acetate, BULK INGREDIENT Regulator openFDA |
| LSNE, Inc. | Octreotide, BULK INGREDIENT Regulator openFDA |
| Matrix Pharmacorp Private Limited | OCTREOTIDE ACETATE, BULK INGREDIENT Regulator openFDA |
| PolyPeptide Laboratories, Pvt. Ltd. | Octreotide Acetate, BULK INGREDIENT Regulator openFDA |
| ScinoPharm Taiwan Ltd. | Octreotide Acetate, BULK INGREDIENT Regulator openFDA |
| Sinopep-Allsino Biopharmaceutical Co., Ltd. | octreotide acetate, BULK INGREDIENT Regulator openFDA |
| Sterling Pharma Solutions Limited | Octreotide acetate, BULK INGREDIENT Regulator openFDA |
| SUN PHARMACEUTICAL INDUSTRIES INC | Octreotide Acetate, BULK INGREDIENT Regulator openFDA |
| USV Private Limited | Octreotide, BULK INGREDIENT Regulator openFDA |
US LABELER
13 companies
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
TRIAL SPONSOR
155 companies
Sponsors registered clinical trials of the peptide.
| Novartis Pharmaceuticals | 21 registered trials Trial register ClinicalTrials.gov |
|---|---|
| Camurus AB | 3 registered trials Trial register EU CTIS 6 registered trials Trial register ClinicalTrials.gov |
| Novartis | 8 registered trials Trial register ClinicalTrials.gov |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 5 registered trials Trial register ClinicalTrials.gov |
| Federico II University | 5 registered trials Trial register ClinicalTrials.gov |
| Aspireo Pharmaceuticals Limited | 4 registered trials Trial register ClinicalTrials.gov |
| Columbia University | 4 registered trials Trial register ClinicalTrials.gov |
| Eastern Cooperative Oncology Group | 4 registered trials Trial register ClinicalTrials.gov |
| Endo USA Inc., a Keenova Therapeutics Company | 4 registered trials Trial register ClinicalTrials.gov |
| Ipsen | 4 registered trials Trial register ClinicalTrials.gov |
| National Cancer Institute (NCI) | 4 registered trials Trial register ClinicalTrials.gov |
| Advanced Accelerator Applications | 1 registered trial Trial register EU CTIS 2 registered trials Trial register ClinicalTrials.gov |
| Alliance for Clinical Trials in Oncology | 3 registered trials Trial register ClinicalTrials.gov |
| Chiasma, Inc. | 3 registered trials Trial register ClinicalTrials.gov |
| Mario Negri Institute for Pharmacological Research | 3 registered trials Trial register ClinicalTrials.gov |
| National Hepatology & Tropical Medicine Research Institute | 3 registered trials Trial register ClinicalTrials.gov |
| Radboud University Medical Center | 3 registered trials Trial register ClinicalTrials.gov |
| Shanghai Zhongshan Hospital | 3 registered trials Trial register ClinicalTrials.gov |
| St. James's Hospital, Ireland | 3 registered trials Trial register ClinicalTrials.gov |
| Universitaire Ziekenhuizen KU Leuven | 3 registered trials Trial register ClinicalTrials.gov |
| Cedars-Sinai Medical Center | 2 registered trials Trial register ClinicalTrials.gov |
| Chemi S.p.A. | 2 registered trials Trial register ClinicalTrials.gov |
| Duke University | 2 registered trials Trial register ClinicalTrials.gov |
| Grupo Espanol de Tumores Neuroendocrinos | 2 registered trials Trial register ClinicalTrials.gov |
| Italfarmaco | 2 registered trials Trial register ClinicalTrials.gov |
| Lexicon Pharmaceuticals | 2 registered trials Trial register ClinicalTrials.gov |
| Mayo Clinic | 2 registered trials Trial register ClinicalTrials.gov |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 registered trials Trial register ClinicalTrials.gov |
| Peking University | 2 registered trials Trial register ClinicalTrials.gov |
| Rayzebio Inc. | 1 registered trial Trial register EU CTIS 1 registered trial Trial register ClinicalTrials.gov |
| Roswell Park Cancer Institute | 2 registered trials Trial register ClinicalTrials.gov |
| Sandoz | 2 registered trials Trial register ClinicalTrials.gov |
| Sue O'Dorisio | 2 registered trials Trial register ClinicalTrials.gov |
| University of Aarhus | 2 registered trials Trial register ClinicalTrials.gov |
| University of Turin, Italy | 2 registered trials Trial register ClinicalTrials.gov |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 registered trial Trial register ClinicalTrials.gov |
| AdventHealth | 1 registered trial Trial register ClinicalTrials.gov |
| AdventHealth Translational Research Institute | 1 registered trial Trial register ClinicalTrials.gov |
| Aga Khan University | 1 registered trial Trial register ClinicalTrials.gov |
| Albert Einstein Healthcare Network | 1 registered trial Trial register ClinicalTrials.gov |
Showing 40 of 155.
RECALLING FIRM
5 companies
Recalled a product naming the peptide (FDA enforcement report).
| Ben Venue Laboratories Inc | Class II recall, Terminated, 2012-06-20 Regulator openFDA |
|---|---|
| Fresenius Kabi USA, LLC | Class II recall, Terminated, 2016-06-01 Regulator openFDA |
| Teva Pharmaceuticals USA | Class II recall, Terminated, 2021-08-25 Regulator openFDA |
| Teva Pharmaceuticals USA, Inc | Class II recall, Ongoing, 2026-04-01 Regulator openFDA Class II recall, Ongoing, 2026-05-13 Regulator openFDA |
| Viatris Inc | Class I recall, Terminated, 2022-11-16 Regulator openFDA |
Every company across all peptides: companies. Names are matched only when identical apart from case and punctuation, so one group can appear under two spellings.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.